Log in to search using one of your social media accounts:

 

Welcoming New Projects and Partners to Address Pain in the Military Population
I am proud to announce NIH ’s newest interagency research initiative on pain management in military service members and veterans. NCCIH, lead for this multi-agency initiative called the NIH-DoD-VA Pain Management Collaboratory, is contributing more than half the funding for these 12 projects to develop, implement, and test nondrug approaches for managing pain and its related conditions in the military and veteran population ―including opioid misuse, abuse, and disorder. The total funding for this project will be $81 million over 6 years.  (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - September 21, 2017 Category: Complementary Medicine Authors: Josephine P. Briggs, M.D. Source Type: news

Lightning Process 'could help children with chronic fatigue syndrome', study claims
Conclusion The results from this very small randomised controlled trial showed that people having LP therapy in addition to usual CFS/ME care had improved physical function, fatigue and anxiety symptoms at six months, and improved school attendance and depressive symptoms at 12 months. However, there are a number of limitations to this research that need to be considered: Participants in both groups improved, so both treatments were effective to some extent. This was a very small trial, and the results analysis involved fewer than the 100 people recruited. It would need to be repeated in a much larger group to demonstr...
Source: NHS News Feed - September 21, 2017 Category: Consumer Health News Tags: Medical practice Source Type: news

Patient Action: As Means and End for Chronic Pain Care Patient Action: As Means and End for Chronic Pain Care
The authors explore the importance of patient action in the self-management of chronic pain.Pain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Federal agencies partner for military and veteran pain management research
Joint HHS-DoD-VA initiative will award multiple grants totaling $81 million. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 20, 2017 Category: American Health Source Type: news

Federal agencies partner for military and veteran pain management research
Joint HHS-DoD-VA initiative will award multiple grants totaling $81  millionU.S. agencies partner on research that focuses on nondrug approaches for pain management in military personnel and veterans; NCCIH is the lead for this multi-agency initiative. (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - September 20, 2017 Category: Complementary Medicine Authors: NCCIH Source Type: news

Medical News Today: Does CBD oil work for chronic pain management?
CBD oil has become popular for pain treatment. We look at how it works, how it is used, and the benefits and risks of using CBD oil for pain management. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 20, 2017 Category: Consumer Health News Tags: Complementary Medicine / Alternative Medicine Source Type: news

Patient satisfaction with pain control linked to nurse staffing
Hospital patient satisfaction with pain management is linked to nurse staffing levels, according to US nursing researchers. (Source: Nursing Times)
Source: Nursing Times - September 20, 2017 Category: Nursing Source Type: news

Milwaukee Hosts PAINWeekEnd CE/CME Pain Management Conference October...
Come to a full day of pain management education for the main street practitioner, mingle with faculty and attendees, learn and earn up to 6.0 AMA PRA Category 1 credits for $129(PRWeb September 19, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14705326.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 19, 2017 Category: Pharmaceuticals Source Type: news

Post PAINWeek National Conference, PAINWeekEnd Regional Meetings...
A full day of pain management education for the main street practitioner; mingle with faculty and attendees, learn and earn up to 6.0 AMA PRA Category 1 credits for $129(PRWeb September 19, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14705395.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 19, 2017 Category: Pharmaceuticals Source Type: news

Medtronic gets FDA clearance for pain management implant that interfaces with Samsung tablet
Medtronic has received FDA clearance for a new implantable pain management device that can be programmed wirelessly via a Samsung tablet. The Intellis system is designed to treat chronic pain by delivering neurostimulation at the spinal cord. Using a Samsung Galaxy Tab S2, the patient's caregiver can adjust the neurostimulation according to a workflow designed by Medtronic called Evolve. (Source: mobihealthnews)
Source: mobihealthnews - September 18, 2017 Category: Information Technology Source Type: news

FDA Clears New Spinal Stimulation Device for Intractable Pain FDA Clears New Spinal Stimulation Device for Intractable Pain
The FDA has approve the   Intellis spinal cord stimulation platform   for the management of chronic intractable pain of the trunk and/or limbs associated with a variety of conditions.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2017 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news

The people of Lancashire deserve more
The impact of austerity is widespread. Spending cuts are painful and cause long-term damage to public services, those who rely on them and those who work in them. That’s not something that will be news to UNISON members or those who rely on their work. Yet after nearly a decade of austerity, there are those who will go through all manner of attempts to deny the impact of pernicious government cuts – even when the realities are staring them in the face. What is currently happening in Lancashire County Council is a classic example. This is the fourth largest county council in the country, yet it’s had to de...
Source: UNISON meat hygiene - September 15, 2017 Category: Food Science Authors: Dave Prentis Tags: General secretary's blog Lancashire local government Source Type: news

Blog: The people of Lancashire deserve more
The impact of austerity is widespread. Spending cuts are painful and cause long-term damage to public services, those who rely on them and those who work in them. That’s not something that will be news to UNISON members or those who rely on their work. Yet after nearly a decade of austerity, there are those who will go through all manner of attempts to deny the impact of pernicious government cuts – even when the realities are staring them in the face. What is currently happening in Lancashire County Council is a classic example. This is the fourth largest county council in the country, yet it’s had to de...
Source: UNISON meat hygiene - September 15, 2017 Category: Food Science Authors: Dave Prentis Tags: General secretary's blog Lancashire local government Source Type: news

SPR Therapeutics raises $25m to support Sprint PNS system
SPR Therapeutics said today it raised $25 million in a Series C round of financing to support commercialization and further research of its Sprint peripheral nerve stimulation system. The round was led by a “prominent family office” and Frontcourt Ventures, the Cleveland-based company said. As part of the funding, the company said it appointed former West Health CEO Nick Valeri to its board of directors. “The SPR Therapeutics leadership team is comprised of recognized experts in the neuromodulation and pain management industries. I am excited to support Maria and her talented team as they make this i...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Pain Management SPR Therapeutics Source Type: news

Study adds to evidence that racial and economic factors affect surgical pain management
(Johns Hopkins Medicine) A 'look back' analysis of more than 600 major colorectal surgeries using a 'checklist' tool has added further evidence that racial and socioeconomic disparities may occur during many specific stages of surgical care, particularly in pain management. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2017 Category: International Medicine & Public Health Source Type: news

SPR Therapeutics gets $25M for pain management wearable
SPR Therapeutics, the Cleveland, Ohio-based developer of a wearable pain management device, announced yesterday the completion of $25 million in Series C financing. (Source: mobihealthnews)
Source: mobihealthnews - September 13, 2017 Category: Information Technology Source Type: news

What You Can Do to Help Fight the Opioid Epidemic
A surgeon's group offers a blueprint for safer pain management Source: HealthDay Related MedlinePlus Pages: Opioid Abuse and Addiction, Pain Relievers (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 13, 2017 Category: Consumer Health News Source Type: news

Gov. Baker On ‘ Encouraging Signs ’ And Challenges Confronting Opioid Crisis
BOSTON (CBS) – It’s been well over a year since Massachusetts Gov. Charlie Baker signed a landmark law to fight the opioid epidemic here in Massachusetts. Since then he has also joined the President Donald Trump’s commission to tackle the crisis nationwide. David Wade sat down with the Governor to talk about what’s working, what we can do better, and how Massachusetts could set an example for other states when it comes to confronting the crisis. David Wade: What is the priority, do you think, for our state? Gov. Baker: I think the big thing is to stay on the stuff that’s we’ve done and r...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 12, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Politics Syndicated Local Charlie Baker Confronting The Crisis David Wade opioid crisis Source Type: news

Here ’s Why Most Americans Prefer to Treat Pain Without Drugs
In the midst of an opioid addiction epidemic, a new survey of Americans has found that most prefer to try a non-drug approach to treating their pain over taking medications prescribed by their doctor. The new report, part of the Gallup-Palmer College of Chiropractic Annual Study of Americans, surveyed about 6,300 adults. Nearly two thirds said that they had neck or back pain so great they sought a health care provider for relief, and 54% said they had neck or back pain for at least five years. Yet 78% said they preferred to try other ways to address their physical pain before taking drugs. Still, many Americans said they ...
Source: TIME.com: Top Science and Health Stories - September 12, 2017 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Addiction Back Pain back pain relief chronic pain Gallup Heroin how to treat back pain how to treat pain natural pain relief Opioid opioids pain killers prescription pain killers Source Type: news

Serving Ambulatory Surgery Centers: A Q & amp;A with DePuy Synthes
With interest in outpatient surgeries continuing to increase, medical device companies should be asking themselves whether their products—as well as their customer support programs—are ready for such a shift.  DePuy Synthes has been equipping ambulatory surgery centers with devices and support needed for orthopedic procedures for many years as ASCs emerged as a burgeoning site of care. MD+DI recently asked Scott Zellner, Senior Director, U.S. Joint Reconstruction and Outpatient Marketing, a few questions about the shift and the company’s approach.   MD+DI: How would the shift of orthopedic...
Source: MDDI - September 12, 2017 Category: Medical Devices Authors: Daphne Allen Tags: Medical Device Business Source Type: news

Brain imaging can't prove chronic pain
A task force of the International Association for the Study of Pain has concluded...Read more on AuntMinnie.comRelated Reading: fMRI, EEG may detect consciousness in TBI patients EEG device could reduce head CT scans Calif. center to explore proton therapy for pain relief Diagnosing chronic back pain: More than just looking at images MR spots reason for chronic groin pain, but may not alter management (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2017 Category: Radiology Source Type: news

EOP: Notification of a Public Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission)
The Office of National Drug Control Policy (ONDCP) will hold its third meeting on Wednesday, September 27, 2017, from 12:30 to 2:30 p.m. Eastern. The meeting will consist of statements from invited stakeholders regarding innovative pain management and prevention measures for diversion, followed by a discussion of the prepared statements. Meeting participation will be available via livestreaming. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - September 11, 2017 Category: Rural Health Source Type: news

Public Inspection: EOP: Meetings: President's Commission on Combating Drug Addiction and the Opioid Crisis
The Office of National Drug Control Policy (ONDCP) will hold its third meeting on Wednesday, September 27, 2017, from 12:30 to 2:30 p.m. Eastern. The meeting will consist of statements from invited stakeholders regarding innovative pain management and prevention measures for diversion, followed by a discussion of the prepared statements. Meeting participation will be available via livestreaming, and final publication in the Federal Register is scheduled for September 11, 2017. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - September 8, 2017 Category: Rural Health Source Type: news

Mainstay Medical taps ex-NuVasive COO Hannon for CEO | Personnel Moves, Sept. 7, 2017
Mainstay Medical (EPA:MSTY) said this week that it tapped former NuVasive Inc. (NSDQ:NUVA) president & COO Jason Hannon to succeed Peter Crosby as CEO, effective Oct. 9. Crosby, recruited in 2009 to lead the company and its development of the Reactiv8 neurostimulation device for treating chronic pain, is slated to act as a consultant for Mainstay through 2020. “Mainstay has made tremendous progress since the founding of the company in 2008 under Mr. Crosby’s leadership, and as we move forward to the next phase we are delighted that Jason is joining as our new CEO. Jason’s broad medical devic...
Source: Mass Device - September 7, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Wall Street Beat AdvaMed avitamedical Axonics Modulation Technologies lightmed Mainstay Medical Monarch Medical qholding venturemed Source Type: news

Current Concepts Burn Rehabilitation, Part II: Long-Term Recovery
This article summarizes current interventions for several of the most common challenges faced by patients during their rehabilitation from burn injury. These challenges include range of motion preservation through scar contracture management, achieving maximal independence through exercise and activities of daily living training, and psychological recovery through nonpharmacologic approaches pain and anxiety (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 7, 2017 Category: Consumer Health News Source Type: news

AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
In clinical studies, elagolix demonstrated superiority compared to placebo in reducing three types of endometriosis-associated pain - daily menstrual pelvic pain, non-menstrual pelvic pain and painful intercourse Endometriosis affects an estimated one i... Biopharmaceuticals, FDA AbbVie, elagolix, endometriosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 6, 2017 Category: Pharmaceuticals Source Type: news

AbbVie Submits New Drug Application to FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
NORTH CHICAGO, Ill., Sept. 6, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), announced that it has submitted a New Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 6, 2017 Category: Drugs & Pharmacology Source Type: news

Patient satisfaction with pain management linked to nurse staffing
(Boston College) Hospital patients' satisfaction with pain management is linked to nurse staffing, according to an article authored by nurse researchers from the Connell School of Nursing at Boston College and published in the journal Pain Management Nursing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 6, 2017 Category: International Medicine & Public Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. How medical device risk management is connected with design controls Medical device design controls play an important role when it comes to risk management, but the relationship isn’t always immediately clear. Intended us...
Source: Mass Device - September 5, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Bioventus wins FDA nod for Durolane OA joint lubrication product
Bioventus said today it won FDA approval for its Durolane injectable product designed for joint lubrication and treating pain associated with knee osteoarthritis. Durolane is a single-injection, hyaluornic acid product designed to lubricate joints to treat pain associated with knee osteoarthritis, Durham, N.C.-based Bioventus said. The company acquired it last December from Galderma for an undisclosed amount. Bioventus said its Durolane product will complement its existing osteoarthritis portfolio, including its 3-injection HA Gelsyn-3 and 5-injection HA Supartz Fx. The company said it plans to launch Durolane in...
Source: Mass Device - September 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Orthopedics Pain Management Regulatory/Compliance Bioventus LLC Source Type: news

Personal Health: Opioids Aren ’ t the Only Pain Drugs to Fear
They are only one of many drug-related problems associated with pain management. (Source: NYT Health)
Source: NYT Health - September 4, 2017 Category: Consumer Health News Authors: JANE E. BRODY Tags: Pain-Relieving Drugs Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Ibuprofen (Drug) Drug Abuse and Traffic Source Type: news

What & #039;s New In Migraine Therapy: An Update for Primary Care
What is first-line Rx for adolescent migraineurs? Ideal management for menstrual migraine? Who will be candidates for the new anti-CGRP preventives? Answers in this Special Report. (Source: ConsultantLive)
Source: ConsultantLive - September 1, 2017 Category: Internal Medicine Authors: Susan Kweskin Tags: Special Report Pain Headache Migraine Source Type: news

Millennials prefer healthy habits over opioids for pain, survey says
A recent survey found that millennials prefer lifestyles changes, such as exercise, over taking opioid medications for management of acute and chronic pain. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 30, 2017 Category: Consumer Health News Source Type: news

Sorrento seeks FDA nod for lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) said today that its subsidiary Scilex Pharmaceuticals resubmitted the new drug application for its lidocaine patch, ZTlido, to the FDA. The San Diego, Calif.-based company is developing the drug-device product for the relief of pain associated with post-herpetic neuralgia. Get the full story at our sister site, Drug Delivery Business News. The post Sorrento seeks FDA nod for lidocaine patch appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 29, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Scilex Pharmaceuticals Sorrento Therapeutics Source Type: news

Electrical nerve-block research aims at asthma, heart failure
(Case Western Reserve University) Biomedical engineering researchers at Case Western Reserve University in Cleveland, Ohio, are refining more than 15 years of work on an electrical nerve-block implant, focusing their next step on new applications related to treating asthma and heart failure. The research builds on applications already in use for pain management and was bolstered recently by a four-year, $2 million National Institutes of Health grant. The research will be conducted in collaboration with teams at UCLA and Johns Hopkins University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2017 Category: International Medicine & Public Health Source Type: news

Gov. Baker: Massachusetts Should Be Model For Opioid Fight
BOSTON (CBS) — Gov. Charlie Baker, who sits on the President’s Commission on Combating Drug Addiction and the Opioid Crisis, says he believes some of what Massachusetts has done to combat opioids should become the national model. The commission was created in March, and the Governor says it has met several times. Baker pointed to the state’s prescription drug monitoring program as an example of a Massachusetts initiative that would work well nationwide. “We doubled the number of inquiries on that prescription management program over the past year or so,” he told WBZ NewsRadio 1030’s Kary...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 27, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Heard On WBZ NewsRadio 1030 Local Syndicated Local Watch Listen Charlie Baker Drugs Karyn Regal opioid crisis White House Source Type: news

HHS Establishing Pain Management Task Force/Seeks Member Nominations
HHS Secretary Tom Price, M.D., announced today the creation of a new Task Force to develop best practices for prescribing pain medication and for managing chronic and acute pain. HHS, which is overseeing this effort with the Secretary of Veterans Affairs and the Secretary of Defense, is seeking member nominations from the public. (Source: HSR Information Central)
Source: HSR Information Central - August 25, 2017 Category: International Medicine & Public Health Source Type: news

Bonti kicks off Ph2 trial for neurotoxin pain-reliever
Privately-held biotech Bonti said today that it launched the Lantern clinical program, evaluating its intramuscular neurotoxin injection as a non-opioid pain reliever. The first clinical trial, Lantern-1, is a Phase II study designed to assess the safety and efficacy of EB-001 in patients undergoing elective breast augmentation. Get the full story at our sister site, Drug Delivery Business News. The post Bonti kicks off Ph2 trial for neurotoxin pain-reliever appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Biotech Clinical Trials Drug-Device Combinations Pain Management Pharmaceuticals bonti Source Type: news

Maryland surgery center plans $1.7 million expansion to meet demand
Bethesda Chevy Chase Surgery Center LLC is seeking state approval for a $1.7 million expansion in order to keep up with growing demand. Officials at the physician-owned outpatient surgery center, located at 6931 Arlington Road in Bethesda, said they hope to acquire 3,027 square feet in their current building to add a second operating room. The center — which performs orthopedic, spine and pain management procedures — said its operating room has exceeded "optimal utilization," as defined by Maryland… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 22, 2017 Category: American Health Authors: Tina Reed Source Type: news

The International Pelvic Pain Society Will Answer, “What’s Going on...
Clinical vignettes and video demonstrations will aid the IPPS in enhancing pain management education during its track presented on Friday, September 8th(PRWeb August 22, 2017)Read the full story at http://www.prweb.com/releases/2017/08/prweb14587935.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 22, 2017 Category: Pharmaceuticals Source Type: news

Maryland surgery center plans $1.7 million expansion to meet demand
Bethesda Chevy Chase Surgery Center LLC is seeking state approval for a $1.7 million expansion in order to keep up with growing demand. Officials at the physician-owned outpatient surgery center, located at 6931 Arlington Road in Bethesda, said they hope to acquire 3,027 square feet in their current building to add a second operating room. The center — which performs orthopedic, spine and pain management procedures — said its operating room has exceeded "optimal utilization," as defined by Maryland… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 21, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

Researchers progress towards vaccine against fentanyl, heroin combo
Researchers reported at the 254th National Meeting & Exposition of the American Chemical Society today that they are developing a vaccine to guard against the effects of fentanyl in combination with heroin – a deadly duo that is claiming a growing number of lives as the opioid crisis worsens in the U.S. “There is an urgent need to discover effective medications to treat substance use disorders. Increasingly, drug users are turning to opioids and powerful synthetic versions of these drugs that can sometimes be as much as 100 times more potent than heroin,” lead researcher Kim Janda said in pr...
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Pain Management Pharmaceuticals Research & Development Scripps Research Institute Source Type: news

Acelity touts lowered complications, narcotic use in Prevena NPWT cesarean trial
This study adds to the growing body of evidence that demonstrates a potential reduction in post-operative wound complications in a variety of surgical incisions,” chief medical officer Dr. Ron Silverman said in a press release. In May, Acelity said it launched its Prevena Duo incision management system in the US. The Prevena Duo is a single use negative pressure wound therapy system specifically designed for the simultaneous management of 2 closed surgical incisions, the company said. The post Acelity touts lowered complications, narcotic use in Prevena NPWT cesarean trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Surgical Wound Care Acelity Source Type: news

An Unexpected Journey
Journey[noun]: The act of travelling from one place to another.By mapping the patient journey – the path taken from diagnosis through treatment to management, recovery or death – pharmaceutical companies are playing an important role in improving patient outcomes.However, the insights emerging from this research can also shape their marketing strategy and activities, says Rebecca Joslin, Head Customer Experience Strategy at Shire.Better understanding of the key touch or pain points across the patient journey allows us to identify opportunities on how we can better support our customers, healthcare professionals...
Source: EyeForPharma - August 21, 2017 Category: Pharmaceuticals Authors: Des Sampson Source Type: news

Combining Medical Interventions and Lifestyle Modifications in the Management of Chronic Pain
Pain is your body’s way of alerting you when something is wrong, which keeps you safe. Pain tells you to stop what you’re doing, to take it easy, or to seek treatment. But what about pain that lingers for weeks, months, or even years? When pain lasts for extended periods of time and disrupts normal life, it is no longer helpful or beneficial; it’s chronic pain, and it affects about 100 million Americans. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - August 18, 2017 Category: Orthopaedics Tags: Featured Spine Articles Source Type: news

South Carolina becomes latest state to sue opioid-maker Purdue
On Tuesday this week, South Carolina became the latest state to sue Purdue Pharma, accusing the drugmaker of deceptively marketing their addictive products in a way that fueled the ongoing opioid crisis. The state’s attorney general said that Purdue told doctors that opioids are not addictive and patients who appear to be addicted were only “pseudoaddicted” and simply needed more drugs. Get the full story at our sister site, Drug Delivery Business News. The post South Carolina becomes latest state to sue opioid-maker Purdue appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 18, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Legal News Pain Management Pharmaceuticals Wall Street Beat purduepharma Source Type: news

Colorado Clinic Welcomes the Addition of Board Certified Pain...
Colorado Clinic announces the addition of Carter Jones, MD, PhD, to the practice. He is a Double Board Certified Colorado pain management doctor and is accepting new patients at the Aurora and...(PRWeb August 17, 2017)Read the full story at http://www.prweb.com/releases/carter-jones-III-md-phd/colorado-clinic/prweb14597018.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 17, 2017 Category: Pharmaceuticals Source Type: news

Inpatient Naloxone Program: Pain Medicine News Report
(MedPage Today) -- Also, guidance on how to study opioid management in children and adolescents (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 16, 2017 Category: American Health Source Type: news

Is there a digital health solution for treating pain?
Could TENS devices be a potential answer to the opioid crisis? If they are, it’ll be thanks to digital health. Case in point is NeuroMetrix’s Quell device. Transcutaneous electrical nerve stimulation (TENS) gizmos have been around for decades. But they’ve had a reputation for being unwieldy, with a bunch of wires and pads. “TENS devices have been around for 40 years, and some of the reasons they’re not effective for chronic pain is that they are underpowered, not designed for 24/7 use, and they’re not dosing at the right levels for t...
Source: Mass Device - August 16, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Health Information Technology mHealth (Mobile Health) Pain Management devicetalksboston Neurometrix Source Type: news